270 related articles for article (PubMed ID: 31003401)
1. MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma.
Sasaki R; Osaki M; Okada F
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31003401
[TBL] [Abstract][Full Text] [Related]
2. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
[TBL] [Abstract][Full Text] [Related]
3. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
4. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.
Zhou G; Shi X; Zhang J; Wu S; Zhao J
J Int Med Res; 2013 Feb; 41(1):1-12. PubMed ID: 23569124
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB
Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs and Potential Targets in Osteosarcoma: Review.
Sampson VB; Yoo S; Kumar A; Vetter NS; Kolb EA
Front Pediatr; 2015; 3():69. PubMed ID: 26380245
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.
Gong L; Bao Q; Hu C; Wang J; Zhou Q; Wei L; Tong L; Zhang W; Shen Y
Biochem Biophys Res Commun; 2018 Jun; 500(2):170-176. PubMed ID: 29626470
[TBL] [Abstract][Full Text] [Related]
11. Emerging Roles of Circular RNAs in Osteosarcoma.
Wang C; Ren M; Zhao X; Wang A; Wang J
Med Sci Monit; 2018 Oct; 24():7043-7050. PubMed ID: 30282962
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression.
Zhang K; Zhang Y; Ren K; Zhao G; Yan K; Ma B
Oncol Rep; 2014 Nov; 32(5):2143-9. PubMed ID: 25190211
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanism of microRNA-128 in osteosarcoma tumorigenesis and evolution through targeting SASH1.
Li Z; Ni J; Song D; Ding M
Oncol Lett; 2018 Jun; 15(6):8687-8694. PubMed ID: 29805606
[TBL] [Abstract][Full Text] [Related]
14. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis.
Jerez S; Araya H; Hevia D; Irarrázaval CE; Thaler R; van Wijnen AJ; Galindo M
Gene; 2019 Aug; 710():246-257. PubMed ID: 31176732
[TBL] [Abstract][Full Text] [Related]
16. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
17. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy.
Izadpanah S; Shabani P; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
Biomed Pharmacother; 2019 Mar; 111():873-881. PubMed ID: 30841466
[TBL] [Abstract][Full Text] [Related]
18. Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma.
Georges S; Calleja LR; Jacques C; Lavaud M; Moukengue B; Lecanda F; Quillard T; Gabriel MT; Cartron PF; Baud'huin M; Lamoureux F; Heymann D; Ory B
Oncotarget; 2018 Nov; 9(87):35726-35741. PubMed ID: 30515265
[TBL] [Abstract][Full Text] [Related]
19. microRNA and Bone Cancer.
Nugent M
Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
[TBL] [Abstract][Full Text] [Related]
20. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.
Salah Z; Arafeh R; Maximov V; Galasso M; Khawaled S; Abou-Sharieha S; Volinia S; Jones KB; Croce CM; Aqeilan RI
Oncotarget; 2015 Mar; 6(7):4920-35. PubMed ID: 25749032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
